Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Niramas Utama Tbk. (JELI) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Niramas Utama Tbk.Trade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Niramas Utama Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Niramas Utama Tbk. trades at Rp515 (market cap 670.98B, 3.31M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Niramas Utama Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 3.31M). Which is the better fit depends on your goals.

JELIPRDL
Market Cap
670.98B428.75B
Volume
3.31M13.83M
Lot
33.07K138.27K
Turnover
1.71B3.27B
Average Price
516.6236.62
Value
1.71B3.27B
Indicative Equilibrium Price
515236
Indicative Equilibrium Volume
6801.74K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JELI
View details
PRDL
View details

About Niramas Utama Tbk.

PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama

Read more on JELI

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL